Research ArticleTheranostics
68Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
Michael M. Graham, Xiaomei Gu, Timothy Ginader, Patrick Breheny and John J. Sunderland
Journal of Nuclear Medicine September 2017, 58 (9) 1452-1458; DOI: https://doi.org/10.2967/jnumed.117.191197
Michael M. Graham
1Division of Nuclear Medicine, Department of Radiology, University of Iowa, Iowa City, Iowa
Xiaomei Gu
2Hardin Library for the Health Sciences, University of Iowa, Iowa City, Iowa; and
Timothy Ginader
3Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
Patrick Breheny
3Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
John J. Sunderland
1Division of Nuclear Medicine, Department of Radiology, University of Iowa, Iowa City, Iowa

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 9
September 1, 2017
68Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
Michael M. Graham, Xiaomei Gu, Timothy Ginader, Patrick Breheny, John J. Sunderland
Journal of Nuclear Medicine Sep 2017, 58 (9) 1452-1458; DOI: 10.2967/jnumed.117.191197
Jump to section
Related Articles
Cited By...
- Imaging of pleural disease
- Treatment Outcomes in Neuroendocrine Prostate Cancer
- The Academic NDA: Justification, Process, and Lessons Learned
- Safety, tolerability and clinical implementation of 'ready-to-use 68gallium-DOTA0-Tyr3-octreotide (68Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
- The Future of Nuclear Medicine as an Independent Specialty
- Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
- Improving Tools and Options for the Management of Patients with Neuroendocrine Tumors: A Patient Perspective